A multigenic approach to predict breast cancer risk.
Armin Gerger1, Uwe Langsenlehner, Wilfried Renner
1Department of Internal Medicine, Division of Oncology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria. armin.gerger@klinikum-graz.at
Breast Cancer Research and Treatment
|October 24, 2006
Summary
Genetic profiles significantly impact breast cancer risk. Specific combinations of gene variations, including vascular endothelial growth factor (VEGF) and matrix metalloproteinase 3 (MMP3), identify individuals at higher risk for this complex disease.
Area of Science:
- Genetics
- Oncology
- Complex Diseases
Background:
- Gene-gene interactions are theorized to be common in complex disorders like breast cancer.
- Understanding genetic contributions is crucial for disease risk assessment.
Purpose of the Study:
- To investigate associations between genetic polymorphisms and breast cancer risk using a multigenic approach.
- To identify specific genetic profiles indicative of increased breast cancer susceptibility.
Main Methods:
- A case-control study involving 500 breast cancer patients and 500 matched healthy controls.
- Classification and Regression Trees (CART) analysis applied to 16 selected polymorphisms.
- Evaluation of individual genetic profiles for classification accuracy.
Main Results:
- Classification accuracy for breast cancer patients and controls was over 79%.
- Key genetic factors identified include VEGF, MMP3, and PTGS2 polymorphisms.
- Thirty distinct genetic profiles were associated with breast cancer, with an odds ratio of 16.12.
- Five genetic profiles represented high-risk subgroups.
Conclusions:
- Distinct genetic profiles significantly increase breast cancer risk.
- A multigenic approach is essential for accurate breast cancer risk assessment.
- This study highlights the importance of gene-gene interactions in breast cancer etiology.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...